Long-acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients with a Continuous-Flow Left Ventricular Assist Device

BACKGROUND: Recurrent gastrointestinal bleeding is one of the most significant adverse events in patients with left ventricular assist devices (LVAD). METHODS: We enrolled LVAD patients who had received an intramuscular injection of 20 mg of octreotide LR every 4 weeks as secondary prevention for re...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Card Fail
Auteurs principaux: Juricek, Colleen, Imamura, Teruhiko, Nguyen, Ann, Chung, Ben, Rodgers, Daniel, Sarswat, Nitasha, Kim, Gene, Raikhelkar, Jayant, Ota, Takeyohi, Song, Tae, Burkhoff, Daniel, Sayer, Gabriel, Jeevanandam, Valluvan, Uriel, Nir
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5897116/
https://ncbi.nlm.nih.gov/pubmed/29427603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2018.01.011
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires